Molecular Biomarkers for Colorectal Liver Metastases Resectability after Chemotherapy with Cetuximab MARCATORI BIOMOLECOLARI DI RESECABILITA' PER METASTASI EPATICHE COLORETTALI TRATTATE CON CHEMIOTERAPIA PIU' CETUXIMAB

Trial Profile

Molecular Biomarkers for Colorectal Liver Metastases Resectability after Chemotherapy with Cetuximab MARCATORI BIOMOLECOLARI DI RESECABILITA' PER METASTASI EPATICHE COLORETTALI TRATTATE CON CHEMIOTERAPIA PIU' CETUXIMAB

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Oct 2012

At a glance

  • Drugs Cetuximab (Primary)
  • Indications Colorectal cancer; Liver metastases
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms POCHER-2
  • Most Recent Events

    • 11 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top